Apyx Medical Corporation (APYX)
NASDAQ:APYX
Want to see APYX full AI Analyst Report?
APYX Stock Chart & Stats
$3.13
-$0.11(-6.43%)
At close: 4:00 PM EST
$3.13
-$0.11(-6.43%)
Day’s Range― - ―
52-Week Range$1.08 - $4.50
Previous CloseN/A
Volume28.06K
Average Volume (3M)120.72K
Market Cap
$153.68M
Enterprise Value$126.91M
Total Cash (Recent Filing)$31.14M
Total Debt (Recent Filing)$4.37M
Price to Earnings (P/E)―
Beta2.01
Next Earnings
Aug 06, 2026EPS Estimate
-0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.22
Shares Outstanding41,873,950
10 Day Avg. Volume65,017
30 Day Avg. Volume120,723
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)10.15
Price to Sales (P/S)2.79
P/FCF Ratio-16.19
Enterprise Value/Market Cap0.83
Enterprise Value/Revenue2.27
Enterprise Value/Gross Profit5.96
Enterprise Value/Ebitda-39.97
Forecast
1Y Price Target
$6.00Price Target Upside91.69% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.32
Revenue Forecast (FY)$57.78M
Bulls Say, Bears Say
Bulls Say
Addressable Market ExpansionAyon's integrated all-in-one body contouring capabilities, combined with growing patient demand for skin tightening linked to GLP-1 medication use, expand the addressable market and encourage adoption by high-volume surgeons.
Commercial TractionStrong U.S. demand for the Ayon system is driving clear commercial traction in the Surgical Aesthetics business, supporting revenue growth and increasing surgeon interest.
Profitability ImprovementApyx's move into adjusted EBITDA profitability reflects effective expense control and cash resources that increase visibility toward sustainable operating profitability.
Bears Say
OEM Segment WeaknessA weaker-than-expected OEM business is putting pressure on the overall sales mix, limiting revenue diversification and weighing on near-term sales performance.
Sales Mix CannibalizationSales representatives prioritizing the Ayon product have reduced domestic generator upgrades, pressuring legacy equipment sales and recurring upgrade revenue.
Apyx Medical News
APYX FAQ
What was Apyx Medical Corporation’s price range in the past 12 months?
Apyx Medical Corporation lowest stock price was $1.08 and its highest was $4.50 in the past 12 months.
What is Apyx Medical Corporation’s market cap?
Apyx Medical Corporation’s market cap is $153.68M.
When is Apyx Medical Corporation’s upcoming earnings report date?
Apyx Medical Corporation’s upcoming earnings report date is Aug 06, 2026 which is in 88 days.
How were Apyx Medical Corporation’s earnings last quarter?
Apyx Medical Corporation released its earnings results on May 07, 2026. The company reported -$0.05 earnings per share for the quarter, beating the consensus estimate of -$0.11 by $0.06.
Is Apyx Medical Corporation overvalued?
According to Wall Street analysts Apyx Medical Corporation’s price is currently Undervalued.
Does Apyx Medical Corporation pay dividends?
Apyx Medical Corporation does not currently pay dividends.
What is Apyx Medical Corporation’s EPS estimate?
Apyx Medical Corporation’s EPS estimate is -0.09.
How many shares outstanding does Apyx Medical Corporation have?
Apyx Medical Corporation has 41,873,950 shares outstanding.
What happened to Apyx Medical Corporation’s price movement after its last earnings report?
Apyx Medical Corporation reported an EPS of -$0.05 in its last earnings report, beating expectations of -$0.11. Following the earnings report the stock price went up 21.918%.
Which hedge fund is a major shareholder of Apyx Medical Corporation?
Currently, no hedge funds are holding shares in APYX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Apyx Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.00 (91.69% Upside)
$6.00 (91.69% Upside)
Hedge Fund Trend
Decreased
By 181.4K Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
129.93%
12-Months-Change
Fundamentals
Return on Equity
-90.62%
Trailing 12-Months
Asset Growth
3.08%
Trailing 12-Months
Company Description
Apyx Medical Corporation
Apyx Medical Corporation (NASDAQ: APYX) is a medical technology company specializing in the development and commercialization of innovative surgical products. The company focuses on two main sectors: surgical energy and cosmetic dermatology. Apyx Medical's core product offerings include the Renuvion® technology, which utilizes helium plasma for skin rejuvenation and various surgical applications, as well as a range of devices designed for energy-based surgical procedures aimed at improving patient outcomes.
APYX Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed substantial positive operational and financial momentum driven by the AYON commercial launch and strong Surgical Aesthetics demand: double-digit revenue growth, expanding gross margins, reduced operating losses, improved adjusted EBITDA, a raised full-year revenue guide, and a healthy cash balance with a runway into 2027. Offsetting risks include a remaining GAAP net loss, tariff-related cost pressure, an expected long-term decline in the OEM business, some domestic generator sales decline/reclassification, and adoption timing dependency on the forthcoming power-liposuction label and international registrations. Overall, the positives—particularly the robust AYON ramp, international traction, margin expansion, and upgraded guidance—significantly outweigh the negatives.View all APYX earnings summariesAPYX Stock 12 Month Forecast
Average Price Target
$6.00
▲(91.69% Upside)
Technical Analysis
Ownership Overview
1.54% Insiders
8.31% Mutual Funds
7.70% Other Institutional Investors
78.60% Public Companies and
Individual Investors